PROVIDER PROFILE · NPI 1548234743
Mary MaierMD
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
94
Unique beneficiaries
—
Total services
120
Distinct HCPCS
5
Medicare payment
$4K
Peer benchmark
Total Medicare services vs. 58 Allergy/ Immunology providers in WA — below median (cohort median 4,111).
PRESCRIBING · PART D · 2024
Total Rx claims
381
Beneficiaries
—
Total drug cost
$644K
Distinct drugs
12
Brand share
73.2%
Top prescribed drugs
Fluticasone/Umeclidin/Vilanter92 claims
Albuterol Sulfate40 claims
Fluticasone Propion/Salmeterol38 claims
Azelastine Hcl31 claims
Montelukast Sodium27 claims
QUALITY · MIPS · 2024
No data available for this provider in 2024.
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2025
No data available for this provider in 2025.
REFERRAL NETWORK
Where Mary Maier's patients come from & go
Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 4 inbound referrers · 0 outbound destinations.
Receives referrals from
Inbound — who sends patients here
| Physician | Patients | Visits |
|---|---|---|
| Quest Diagnostics Clinical Laboratories Inc Clinical Laboratory · Seattle, WA | 27 | 66 |
| Kittredge Baldwin Pulmonary Disease · Silverdale, WA | 18 | 53 |
| JEFFERSON COUNTY PUBLIC HOSPITAL DISTRICT NO 2 | 18 | 133 |
| Unilab Corporation Clinical Laboratory · West Hills, CA | 14 | 32 |
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
CROSS-REFERENCE